Condition: Respiratory Failure · Interstitial Lung Disease · Lung Diseases · Sponsor: Baylor Research Institute
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
This description comes directly from the study's public registry record.
Susan Mathai, MD · 214-820-6856 · Susan.Mathai@bswhealth.org
Tammy Fischer · Tammy.Fisher@BSWHealth.org
Always discuss trial participation with your own doctor first.
| Baylor Scott & White Research Institute | Dallas, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04664192